Although arginase II (ArgII) is abundant in mitochondria, Ca 2+ -accumulating organelles, the relationship between ArgII activity and Ca 2+ translocation into mitochondria and the regulation of cytosolic Ca 2+ signaling are completely unknown. We investigated the effects of ArgII activity on mitochondrial Ca 2+ uptake through mitochondrial p32 protein (p32m) and on CaMKII-dependent vascular smooth muscle cell (VSMC) contraction. Native low-density lipoprotein stimulation induced an increase in [Ca 2+ ]m as measured by CoCl 2 -quenched calcein-AM fluorescence, which was prevented by Arg inhibition in hAoSMCs and reduced in mAoSMCs from ArgII −/− mice. Conversely, [Ca 2+ ]c analyzed with Fluo-4 AM was increased by Arg inhibition and ArgII gene knockout. The increased [Ca 2+ ]c resulted in CaMKII and MLC 20 phosphorylation, which was associated with enhanced vasoconstriction activity to phenylephrine (PE) in the vascular tension assay. Cy5-tagged siRNA against mitochondrial p32 mRNA (sip32m) abolished mitochondrial Ca 2+ uptake and induced activation of CaMKII. Spermine, a polyamine, induced mitochondrial Ca 2+ uptake and dephosphorylation of CaMKII and was completely inhibited by sip32m incubation. In mAoSMCs from ApoE-null mice fed a high-cholesterol diet (ApoE −/− +HCD), Arg activity was increased, and spermine concentration was higher than that of wild-type mice. Furthermore, [Ca 2+ ]m and p32m levels were elevated, and CaMKII phosphorylation was reduced in mAoSMCs from ApoE −/− +HCD. In vascular tension experiments, an attenuated response to vasoconstrictors in de-endothelialized aorta from ApoE −/− +HCD was recovered by incubation of sip32m. ArgII activity-dependent production of spermine augments Ca 2+ transition from the cytosol to the mitochondria in a p32m-dependent manner and regulates CaMKII-dependent constriction in VSMCs.
Introduction
Arginase hydrolyzes L-arginine to urea and L-ornithine, a precursor for polyamines, including spermine, spermidine, and putrescine. Two isoforms of arginase are found in a variety of cells and may be expressed in species-and tissue-specific manners [1] [2] [3] [4] [5] . Arginase I (ArgI) is found in the cytosol, and arginase II (ArgII) is targeted to the mitochondria. Although ArgI can stimulate proliferation through a polyamine-dependent mechanism in aortic smooth muscle cells 6 , the mechanism underlying the role of ArgII in mitochondrial function is yet unknown. We previously demonstrated that ArgII played an important role in the regulation of mitochondrial Ca 2+ concentration in native low-density lipoprotein (nLDL)-treated hAoSMCs, although we did not define the target protein 7 .
Together with the endoplasmic reticulum, the mitochondria play a critical role as a Ca 2+ -handling organelle in cells, and mitochondrial Ca 2+ influx from the cytosol affects cellular physiology and pathophysiology through contributions to the spatial and temporal profiles of intracellular Ca 2+ 8 . The activated CaMKII provokes vascular smooth muscle cell (VSMC) contraction through interactions with myosin light chain kinase (MLCK), leading to MLC phosphorylation and actin-myosin interaction 9, 10 . Furthermore, increased levels of intracellular Ca 2+ may function as a second messenger to activate other signaling molecules [11] [12] [13] . Initially, p32 was characterized as a pre-mRNA splicing factor SF-2 associated protein 14 , as hyaluronan-binding protein 1 (HABP1), as receptor for globular head domains complement 1q (gC1qR), or as complement 1q binding protein (C1qbp) 15 . Moreover, p32 is a conserved eukaryotic protein that exists in multiple subcellular compartments [16] [17] [18] . However, recent studies have demonstrated that p32 is primarily targeted to the mitochondria because the 73 N-terminal amino acids contain a mitochondrial localization sequence 19 . Mitochondrial p32 protein has been studied previously in cancer development in the context of mitochondrion morphology 20 , the maintenance of oxidative phosphorylation 21 , and ARF-induced apoptosis 22 . However, the primary function of p32 in the mitochondrion is yet unknown.
Although arginase activity in VSMCs provokes cell proliferation in a polyamine-dependent manner 6 , the protein regulated by arginase activity and its function in the mitochondrion are not yet known. To determine the physiological contribution of ArgII activity to vasoconstriction in VSMCs from humans and mice, we investigated how ArgII activity modulates [Ca 2+ ]c and [Ca 2+ ]m through p32. Furthermore, we tested the underlying mechanism of p32-dependent vasoconstriction in deendothelialized vessels.
Materials and methods

Materials
We purchased 2(S)-amino-6-boronohexanoic acid (ABH) from Calbiochem (La Jolla, CA, USA 
Isolation of nLDL and cell culture
The nLDL (density 1.019-1.063 g ml ) was prepared from the plasma of normocholesterolemic subjects by differential ultracentrifugation as previously described 7 . Isolated nLDL did not exhibit oxidative modification within 3 weeks compared with the oxidation of commercial nLDL and oxidized LDL from Intracel (Frederick, MD, USA), as determined by thiobarbiturate-reactive substance assays using malondialdehyde as a standard.
Human aortic smooth muscle cells (hAoSMCs) from four different batches were purchased from Lonza, Co. (Allendale, NJ, USA), maintained in medium 231 supplemented with SMGS (Cascade Biologics, Portland, OR, USA) according to the manufacturer's protocol and treated with nLDL (final concentration, 100 µg/ml) after incubation in starvation medium (DMEM, 0.1% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin) for 24 h. mAoSMCs of at least eight different batches were isolated from the thoracic and upper parts of the abdominal aorta of 10-week-old male mice (C57BL/6) as previously described 23 with minor modifications. Briefly, the stripped aorta was prepared from the anesthetized mice and cut into 2-mm pieces, which were treated with type II collagenase (1 mg/ml, Invitrogen, Carlsbad, CA, USA) for 1 hr to remove the endothelial cells. The deendothelialized aortic pieces were incubated with culture medium on gelatin (0.1%)-coated culture dishes for approximately 10 days. The cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 8 mM HEPES, and 2 mM glutamine at 37°C in a humidified 5% CO 2 incubator. Before all experiments, isolated mAoSMCs at passage numbers 1-3 were maintained for 24 h in starvation medium to maintain their contractile phenotype. mAoSMCs were identified by their 'spindle-shaped' pattern and further confirmed by double staining using platelet endothelial cell adhesion molecule-1, a specific marker for endothelial cells, and α-smooth muscle actin, a specific marker for SMCs. All cells were stained with anti-α-smooth muscle actin antibodies. Each experiment was performed in at least two different batches of VSMCs depending on the availability of the cells.
Animals
The study was approved in accordance with the Guide for the Care and Use of Laboratory Animals (Institutional Review Board, Kangwon National University). Studies were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Three pairs of ArgII −/− mice with a C57BL/6 background were gifted generously by Prof. Jaye ChinDusting to establish a colony. Mice were anaesthetized by 2.5% isoflurane in O 2 and subjected to the following experiments. Aortic rings were studied from ten 10-weekold male C57BL/6 WT mice fed a normal diet (ND) and ten 10-week-old male ApoE −/− mice (Daehan Biolink, Co.) fed a high-cholesterol diet (HCD, D12108C, Research Diet, Inc., USA) for 8 weeks 1, 24 .
Arginase activity
Arginase activity was determined from urea concentration measurements as described previously 4 .
[ ]m and [Ca 2+ ]c were also determined using flow cytometry (FACSCalibur). The fluorescence intensity for each sample was determined using CellQuest software. The Ca 2+ level was determined by comparing the fold changes in the fluorescence intensities of treated cells versus control cells.
siRNA treatment and knockdown of (p32)m Serum-starved hAoSMCs were incubated in starvation medium containing sip32m (100 nM, 5′-TGT CTC CGT CGG TGT GCA GC-Cy5-3′), scm siRNA (100 nM, 5′-GCT GCA CAC CGA CGG AGA CA-Cy5-3′) or no oligonucleotide for 24 h without a transfection reagent. Dissected thoracic aorta from mice were incubated for 24 h in DMEM (2% FBS, penicillin (100 U/ml) and streptomycin (100 μg/ml)) containing sip32m (100 nM, 5′-TGT CTC CTT CCG TGT GCA GA-Cy5-3′) and scm siRNA (100 nM, 5′-CAG CAC AGC CCT GGA GCA CC-Cy5-3′).
Mitochondria fractionation
Cells and de-endothelialized aortic segments were homogenized twice in subcellular fractionation buffer (250 mM sucrose, 20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, and protease inhibitors) (Roche, Co., Basel, Switzerland) for 3 min and centrifuged at 1000 × g for 10 min to remove cell debris and unbroken cells. The supernatants were centrifuged at 21,000 × g for 45 min at 4°C. The cytosolic (supernatant) and mitochondrial (precipitate) fractions containing 20 μg proteins were used for subsequent western blotting analyses of p32 protein expression.
Western blot analysis
Cell extract and tissue extract were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed for the densitometry of bands using ImageJ from the National Institutes of Health (NIH) 4 .
Fluorescence detection in aortic tissues
De-endothelialized aortic vessels treated with Cy5-conjugated sip32m and scm siRNA for 24 h were fixed in 4% formaldehyde, and frozen sections (5 μm) were used for the detection of Cy5 fluorescence. The slides were examined under a fluorescence microscope (Olympus) linked to a Clara EMCCD digital camera (Andor Technol.) and collected using MetaMorph software.
Polyamine analysis
Intracellular concentrations of L-arginine and polyamine, spermine, spermidine, and putrescine were determined by HPLC using pre-column derivatization with o-phthalaldehyde (OPA) according to a modification of previously published methods 26 . Briefly, L-arginine (100 μM) and polyamine (30 μM/each) were added to cell lysate (0.1 mM) as an internal standard. The samples were extracted on solid-phase extraction cartridges (CBA Bond elute, Varian, Yverdon, Switzerland), and the recovery rate was 87.5 ± 3.9% for L-arginine. Eluates were dried over nitrogen and resuspended in double-distilled water for HPLC analysis. HPLC was performed on a computercontrolled Waters chromatography system (M600E) consisting of an automatic injector (M7725i, Waters Co., Easton, MA, USA) and a fluorescence detector (FP-1520, Jasco Co., Easton, MA, USA). Samples were incubated for 1 min with OPA reagent (5.4 mg/ml OPA in borate buffer, pH 8.4, containing 0.4% 2-mercaptoethanol) before automatic injection to the HPLC. The OPA derivative of L-arginine was separated on a 150 × 4.6 mm-5 μm Zorbax Eclipse (Agilent Technologies, Santa Clara, CA, USA) XDB-C18 column with the fluorescence detector set at Ex 340 nm and Em 450 nm. Samples were eluted from the column with 0.96% citric acid/methanol (70:30), pH 6.8 at a flow rate of 1.5 ml/min.
Vessel reactivity assay
The thoracic aorta was dissected from anesthetized mice (C57BL/6) with isoflurane, and fat and connective tissues were cleaned. The aorta was cut into 1.5-mm rings, and the endothelium was removed gently using a wooden stick. Then, the samples were suspended between two wire stirrups (150 μm) in a myograph (Multi myograph system DMT-620, Aarhus, Denmark) in 10 ml Krebsringer solution (95% O 2 , 5% CO 2 , pH 7.4, 37°C). One stirrup was connected to a three-dimensional micromanipulator and the other to a force transducer. The rings were passively stretched at 10-min intervals in 100 mg increments to reach optimal tone (600 mg). After the arterial rings had been stretched to their optimal resting tone, the contractile response to 100 mM KCl was determined. The response to a maximal dose of KCl was used to normalize the agonist responses across vessel rings. Dose responses to the vasoconstrictor PE (10 −10 -10 −6 M) and NE (10 −9 -10 −5 M) were performed.
Statistical analyses
All data are reported as the mean ± SEM. ]c in nLDLstimulated hAoSMCs
We first wished to determine the effect of ArgII inhibition on mitochondrial Ca 2+ uptake in cultured hAoSMCs ( Supplementary Fig. 1A ). nLDL stimulation for 30 min resulted in increased [Ca 2+ ]m (Fig. 1a , * vs. untreated, 147 ± 6.6 vs. 100 ± 7.9%, P < 0.01), which was abolished by pretreatment with the ArgII inhibitor ABH and small interfering RNA against ArgII (siArgII) (Fig. 1a , ** vs. nLDL only, P < 0.01. Supplementary Fig. 1A (Fig. 1d , * vs. untreated, 71.5 ± 8.1 vs. 100 ± 6.5%, P < 0.01), and [Ca 2+ ]c in mAoSMCs from ArgII −/− mice was higher (** vs. WT + untreated, 100 ± 6.5 vs. 131.4 ± 6.1%, P < 0.01) and not affected by nLDL (ArgII −/− vs. ArgII −/− +nLDL, ns). The results from microscopic images were confirmed again with FACS analysis (Fig. 1e-h , * vs. untreated, P < 0.01; # vs. nLDL only, P < 0.01).
Downregulation of ArgII activity induces CaMKII/MLC20 phosphorylation, which contributes to vessel constriction in de-endothelialized aortas
To assess the hypothesis that nLDL treatment decreased [Ca 2+ ]c, we measured the activation of a Ca 2+ -dependent protein kinase, CaMKII, which was related to VSMC constriction. As shown in Fig. 2a , nLDL stimulation attenuated CaMKII phosphorylation in a time-dependent manner. Next, we tested whether downregulation of ArgII activity recovered nLDL-dependent CaMKII dephosphorylation. ArgII downregulation with ABH (Fig. 2b, untreated, 100 ± 5.1, nLDL, 52 ± 4.2, ABH, 168 ± 11.3, nLDL+ABH, 97.6 ± 7.1 Arbitrary unit (AU)) and siArgII (Fig. 2c , untreated, 100 ± 10.2, nLDL, 60.9 ± 8.5, siArgII, 166.1 ± 12.6, nLDL+siArgII, 165.2 ± 10.1 AU) induced an increase in CaMKII phosphorylation, and CaMKII phosphorylation was enhanced in de-endothelialized aortas from ArgII −/− (Fig. 2d , WT, 100 ± 11.2, ArgII −/− , 179 ± 16.8 AU). Elevated CaMKII phosphorylation by ArgII downregulation was associated with MLC20 phosphorylation. As shown in Fig. 2e , nLDL incubation significantly reduced MLC20 phosphorylation in de-endothelialized aortas from WT, but MLC20 phosphorylation was enhanced in de-endothelialized aortas from ArgII −/− and maintained at high levels even with nLDL stimulation (WT, 100 ± 11.2, WT + nLDL, 79.1 ± 13.2, ArgII −/− , 179.0 ± 16.8, ArgII −/− ± nLDL, 150.1 ± 15.3 AU). MLC20 phosphorylation in de-endothelialized vessels (Fig. 2f) was clearly correlated with phenylephrine (PE)-dependent vasoconstriction activity (Fig. 2g, Emax, uptake into mitochondria, scramble (scm) and siRNA oligonucleotides against mitochondrial p32 (sip32m) mRNA were designed. Incubation of sip32m with hAoSMCs at 100 nM for 24 h reduced the p32m level without affecting the p32c level (Fig. 3a) . Both sip32m and scm siRNA were taken up into cells (Fig. 3b upper, from Cy5 image), and sip32m abolished Ca 2+ transition to the mitochondria by nLDL stimulation (Fig. 3b , lower, * vs. untreated, P < 0.01; ns, not significant). Furthermore, as revealed by the sip32m-dependent increase in [Ca 2+ ]c (Fig. 3c) , sip32m restored the attenuated CaMKII phosphorylation by nLDL ]c d levels were examined with or without nLDL treatment. * vs. WT + untreated, P < 0.01, ** vs. WT + untreated, P < 0.01. All statistical analyses were performed using an unpaired t-test. n = 3 independent experiments, and fluorescent intensity was quantified from 9-15 images per experiment. Bars indicate 10 μm (a, b, c) and 50 μm (d). FACS analyses were performed to confirm the data from microscopic analyses (E-H). Arginase inhibition with ABH (e, f) and siArgII (g, h) increased [Ca 2+ ]c and reciprocally decreased [Ca 2+ ]m. * vs. untreated, P < 0.01. # vs. nLDL, P < 0.01. n = 3 independent experiments stimulation (Fig. 3d) . However, the mitochondrial permeability transition pore and mitochondrial Ca 2+ uniporter were not involved in the mitochondrial Ca 2+ transition in nLDL-stimulated hAoSMCs ( Supplementary  Fig. 2 ).
Spermine induces a p32-dependent increase in [Ca 2+ ]m that attenuates CaMKII phosphorylation
To test whether ArgII activity impacts p32-dependent mitochondrial Ca 2+ uptake, cells were incubated with polyamines, spermine, spermidine, and putrescine, without siRNA. Interestingly, only spermine treatment induced an increase in [Ca 2+ ]m (Fig. 4a , * vs. untreated, 126 ± 8.9 vs. 100 ± 12.5%, P < 0.05), while spermidine and putrescine had no effect. To confirm the association between spermine-dependent mitochondrial Ca 2+ uptake and p32m, cells were preincubated with sip32m and scm siRNA and then stimulated with polyamine. Indeed, sip32m treatment prevented spermine-induced mitochondrial Ca 2+ uptake (Fig. 4a , 104 ± 5.9 vs. 102 ± 4.6%, ns), but scm treatment produced no effect (Fig. 4a , middle column, * vs. untreated, 106 ± 4.7 vs. 124 ± 5.8%, P < 0.01). We next tested whether the incubation of spermine affects CaMKII phosphorylation. As shown in Fig. 4b , spermine treatment significantly reduced CaMKII phosphorylation (* vs. untreated, 25 ± 3.9 vs. 100 ± 5.1 AU, P < 0.01). The effect of spermine on CaMKII phosphorylation was prevented by sip32m incubation (Fig. 4c) , but scm did not affect CaMKII activation (Fig. 4d) . Because spermine-induced mitochondrial Ca 2+ transition through p32m and arginase inhibition decreased mitochondrial Ca 2+ levels, we tested whether arginase inhibition had an effect on spermine levels. As shown in Fig. 4e , arginase inhibition reduced intracellular spermine levels (* vs. untreated, 19.4 ± 0.6 vs. 10.9 ± 3.6 μmol/L, P < 0.01). Therefore, we suggest here that ArgII inhibition attenuates [Ca 2+ ]m by decreasing the level of spermine inducing the p32-dependent transition of cytosolic Ca 2+ into the mitochondria.
sip32m incubation enhances responses to vasoconstrictors
We next tested whether sip32m could regulate VSMC constriction. First, sip32m incubation with deendothelialized rings from WT mice significantly reduced the p32m level at 100 nM, but scm siRNA had no effect on the protein level (Fig. 5a , * vs. untreated, P < 0.01; # vs. untreated, P < 0.01). To examine the movement of Cy5-conjugated siRNA into cells, the vessels were imaged with Cy5 fluorescence (Fig. 5b) . We observed its transfer into VSMCs. In the vascular tension assay against Fig. 2 Arginase II activity regulates CaMKII/MLC20 phosphorylation and vessel constriction. Western blotting analysis was performed to determine CaMKII phosphorylation after the treatment of nLDL (100 μg/ml) for different time points (a, * vs. untreated, P < 0.01), after the stimulation of nLDL in the pretreatment (30 min) of ABH (b) and siArgII (c, * vs. untreated, P < 0.01; # vs. untreated, P < 0.01; ** vs. nLDL, P < 0.01), and in the isolated mAoSMCs from WT and ArgII −/− mice (d, * vs. WT, P < 0.01). MLC-20 phosphorylation was also examined after nLDL stimulation using isolated mAoSMCs (e, * vs. WT+untreated, P < 0.05; # vs. WT+untreated or nLDL treated, P < 0.01). Aortic rings were de-endothelialized and had no response to Ach (f, NS not significant). Vessel reactivity of de-endothelialized rings against a vasoconstrictive agonist, PE (10 -9 -10 -5 M), was tested (g, *, WT vs. ArgII −/− , P < 0.01; **, WT vs. WT + nLDL, P < 0.01; ***, WT + nLDL vs. ArgII −/− + nLDL, P < 0.01). n = 4 independent experiments agonists, norepinephrine (NE) and phenylephrine (PE), sip32m incubation enhanced the Emax values to NE (Fig.  5c , *, untreated vs. sip32m, 122.4 ± 6.9 vs. 175.6 ± 4.3%, P < 0.01) and PE (Fig. 5d, * Compared to the results from WT mice, we examined whether the expression of p32m was altered in an atherogenic mouse model (ApoE −/− ) fed a highcholesterol diet (HCD). Arg activity was increased in deendothelialized aortas of ApoE −/− mice fed an HCD (Fig.  6a , * vs. WT+ND, 120 ± 1 vs. 100 ± 2%, P < 0.01). In addition, the level of L-arginine was decreased (* vs. WT + ND, 68.7 ± 10 vs. 100 ± 1%, P < 0.01), while the concentrations of polyamine, spermine (# vs. WT + ND, 138.6 ± 0.9 vs. 100 ± 3%, P < 0.01), spermidine (# vs. WT +ND, 148.9 ± 5% vs. 100 ± 2%, P < 0.01), and putrescine (# vs. WT+ND, 242.7 ± 3% vs. 100 ± 4%, P < 0.01) were increased (Fig. 6b) . Furthermore, [Ca 2+ ]m was also elevated (Fig. 6c , * vs. WT + ND, 111.8 ± 2 vs. 100 ± 2%, P < 0.05) and [Ca 2+ ]c was reduced (Fig. 6d , * vs. WT + ND, 84.0 ± 4.7 vs. 100 ± 5.5%, P < 0.05) in isolated mAoSMCs from ApoE −/− fed an HCD, which was consistent with the augmented p32m expression (Fig. 6e , * vs. WT + ND, 321 ± 26.1 vs. 100 ± 5.8 AU, P < 0.01) and attenuated CaMKII activation (Fig. 6f , * vs. WT + ND, 24 ± 11 vs. 100 ± 19 AU, P < 0.01) in de-endothelialized aortas of ApoE −/− mice fed an HCD. The increased p32m expression in ApoE −/− fed an HCD might be dependent on the diet type because mice fed an ND did not show changes in p32m expression (Supplementary Fig. 3 ).
Effect of p32m on vasoconstriction in ApoE
−/− mice fed an
HCD
In de-endothelialized aortas from WT fed an ND and ApoE −/− mice fed an HCD, sip32m treatment significantly reduced the p32m level (Fig. 7a) . With the same treatment, accumulated vasoconstrictor responses to PE and NE were constructed. The attenuated vasoconstriction responses to PE in aortas from ApoE −/− mice fed an HCD compared to WT mice fed an ND were improved with sip32m incubation (Fig. 7b , *, WT + ND vs. ApoE −/− + HCD, 158.5 ± 22.3 vs. 47.1 ± 8.1%, P < 0.01, **, ApoE −/− + HCD vs. ApoE −/− + HCD+sip32 m, 47.1 ± 8.1 vs. 126.9 ± 43.9%, P < 0.01). Consistent with these data, the responses to NE were similar to PE responses (Fig. 7c, no response to an endothelium-dependent vasorelaxant, acetylcholine (Ach, Fig. 7d ).
Discussion
In this study, we demonstrated for the first time that the activity of ArgII, a mitochondria-targeting Arg isoform, regulates mitochondrial Ca 2+ transition and CaMKII activation via spermine/p32m-dependent mitochondrial Ca 2+ uptake in VSMCs. Furthermore, downregulation of p32m using siRNA resulted in increased [Ca 2+ ]c and CaMKII/MLC20 phosphorylation and enhanced vasoconstriction in de-endothelialized aortic vessels. In deendothelialized aortas from ApoE −/− mice fed an HCD, both Arg activity and spermine levels increased. Interestingly, p32m was upregulated and [Ca 2+ ]m was augmented in mAoSMCs from atherogenic mice. Consistent with the above data, CaMKII phosphorylation was decreased and vascular tension in response to vasoconstrictors was attenuated in de-endothelialized aortas from ApoE −/− mice fed an HCD. However, incubation with sip32m restored responses to the vasoconstrictors.
Increased Arg activity contributes to the pathophysiology of various disease processes. Vascular endothelial Arg leads to endothelial dysfunction by substrate depletion and contributes to vascular diseases 24, [27] [28] [29] [30] . Consistent with these observations, long-term administration of Larginine in some preclinical studies has been shown to prevent atherosclerosis and myointimal hyperplasia and enhance angiogenesis [31] [32] [33] . However, in patients with peripheral arterial disease, long-term L-arginine administration resulted in increased levels of ornithine and urea and did not improve vascular reactivity 34 . This discrepancy may be partly explained by our study demonstrating that increased Arg activity provoked the production of spermine, which may induce mitochondrial Ca 2+ uptake via p32m. This phenomenon is a reason for mitochondrial dysfunction. Increased Ca 2+ uptake into mitochondria becomes a pathological stimulus by promoting ROS generation, cytochrome C release, and apoptosis [35] [36] [37] . Mitochondrial Ca 2+ transport plays a central role in cellular physiology and pathophysiology. Ca 2+ influx from the cytosol can control the rate of mitochondrial energy production through activation of pyruvate dehydrogenase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase in the Krebs cycle 38 and through regulation of ]m that prevented incubation of sip32 (a, lower, * vs. untreated, P < 0.05). n = 3 independent experiments and 10-12 different images were obtained in each experiment. b Spermine decreased CaMKII phosphorylation in nLDL-treated hAoSMCs (* vs. untreated, P < 0.05). Incubation of sip32 restored nLDL-and spermine-induced decreases in CaMKII phosphorylation (c), but scm siRNA had no effect on CaMKII phosphorylation (d). All blots are representative of three independent experiments. e Arginase inhibition with ABH (10 μM) reduced intracellular spermine concentration (top, representative HPLC chromatogram, * vs. untreated, P < 0.05). n = 4 experiments FoF1ATPase 39 and adenine nucleotide translocase 40 activity in the electron transport chain. Thus, increased Ca 2+ uptake into the mitochondria in nLDL-stimulated VSMCs appears to be a natural phenomenon, as nLDL primarily serves to supply lipids and is then catabolized through β-oxidation in mitochondria to acetyl-CoA, which is utilized for the production of energy (ATP). Our study showed that nLDL stimulation exerted an increase in [Ca 2+ ]m that was prevented by Arg inhibition (Fig. 1a ) and ArgII gene deletion (Fig. 1c) . However, [Ca 2+ ]c was decreased by nLDL stimulation that was also recovered by downregulation of Arg activity (Fig. 1b, d ) and resulted in activation of a Ca 2+ -sensitive protein kinase, CaMKII (Fig.  2) . In this study, we illustrate a mechanism in which mitochondrial dysfunction is an early phenomenon of cardiovascular diseases initiated by hypercholesterolemia. Our findings are consistent with previous demonstrations that the mitochondria decode and shape cellular Ca 2+ signals [40] [41] [42] by uptake and release of Ca 2+ ions to modulate cell metabolism and cell death 43 . The main transporters contributing to rapid Ca 2+ uptake into the mitochondria are reported 44 ; herein, we present for the first time a role for p32m as a novel mitochondrial Ca 2+ transporter. Indeed, p32m could form a doughnut-shaped trimer with 48 amino acids, aspartic and glutamic acids, distributed on the surface of the trimer. With its acidic surface, p32m has been suggested as a high-capacity divalent cation storage protein modulating mitochondrial cation concentrations 45 . Consistent with this assumption, we confirmed that p32m is involved in Ca 2+ uptake using siRNA (Fig. 3b) . Furthermore, p32m-dependent entry of Ca 2+ into the mitochondria was enhanced with spermine treatment (Fig. 4a) , and spermine pretreatment attenuated CaMKII phosphorylation (Fig. 4b) . These observations were consistent with a previous report that spermine can play an important role in the regulation of the free cytoplasmic Ca 2+ concentration and of the free Ca 2+ concentration in the mitochondrial matrix, while the responsible channel protein was not identified 46 .
Increased [Ca 2+ ]m was shown to regulate cell metabolism 38 , and p32m was shown to be a regulator for maintenance of oxidative phosphorylation 21 . In tumor cells, p32m knockdown cells shift their metabolism from oxidative phosphorylation toward glycolysis 21 . Based on these results, we wanted to confirm the function of p32m in Ca 2+ -dependent contraction in VSMCs. As shown in ]c intensification. In VSMCs from ApoE-null mice fed an HCD, we found that the p32m levels were upregulated and [Ca 2+ ]m was augmented ( Fig. 6c and E) . Indeed, Arg activity increased in ApoE −/− mice fed an HCD, spermine concentration was high, and CaMKII phosphorylation was significantly attenuated compared to WT mice fed an ND (Fig. 6a, b,  and F) . Furthermore, the downregulation of increased p32m using sip32m restored attenuated contraction responses (Fig. 7) . These results suggested that p32m expression may be regulated by Arg activity because p32m was downregulated in ArgII In this current study, two major points should be explained. The first is why [Ca 2+ ]c was maintained at higher levels by downregulating Arg activity than that of untreated cells (Fig. 1b) , although Arg inhibition reduced the increases in [Ca 2+ ]m in nLDL-stimulated hAoSMCs to untreated levels. A possible reason is L-arginine content. Temporary inhibition of Arg activity definitely elicited a decrease in intracellular spermine amount and an increase in intracellular L-arginine levels 47 . Interestingly, incubation of cells with L-arginine increased intracellular [Ca 2+ ]c levels (data not shown). Therefore, higher [Ca 2+ ]c by transient inhibition of Arg activity (Fig. 1b) may be attributed to increased intracellular L-arginine contents. The second explanation is that [Ca 2+ ]m in mAoSMCs from ArgII −/− mice was maintained at lower levels than that of WT cells and not increased under nLDLstimulated conditions. As shown in Supplementary Fig.  4 , p32m levels were clearly downregulated, and PE-dose ]c. In conclusion, we demonstrated that ArgII activity, coupled with spermine production, contributes to mitochondrial dysfunction through increased p32m-dependent mitochondrial Ca 2+ uptake. In particular, p32m levels were upregulated, and [Ca 2+ ]m levels were increased in VSMCs from ApoE −/− mice. Finally, downregulation of p32m using the siRNA technique augmented CaMKII phosphorylation and agonist-induced vasoconstriction activity. aortas from WT mice fed an ND and ApoE −/− mice fed an HCD for 8 weeks were incubated with sip32 and scm siRNA. Incubation of sip32 resulted in a decrease in mitochondrial protein levels (a, representative blot from three independent experiments). In a vascular tension assay using deendothelialized aortas with vasoconstrictive agonists, PE (b) and NE (c), the decreased constriction in aortas from ApoE −/− mice fed an HCD was restored with incubation of sip32 (*, P < 0.01, **, P < 0.01). n = 4 mice. All groups showed no responses to Ach (d)
